West Lake Dermatology

MARCH 25, 2024

Seborrheic Dermatitis (SD) is common skin condition known for its chronic and recurrent nature. Understanding seborrheic dermatitis is the first step towards managing it effectively. What Is Seborrheic Dermatitis? Who’s At Risk For Developing Seborrheic Dermatitis? SD can affect individuals of all ages and races.

Dermatitis 36

Dermatitis Treatments Eczema Management 36

The Dermatology Digest

AUGUST 21, 2024

Childhood obesity can contribute to the development of common immune-mediated skin diseases (IMSDs), such as alopecia areata, atopic dermatitis, and psoriasis, new research finds. The study, which appears in the Journal of Investigative Dermatology , comprises an analysis of 2,161,900 Korean children followed from 2009 to 2020.

Dermatitis 69

Dermatitis Diet Dermatology Medical 69

First Derm

APRIL 5, 2024

Ensuring adherence to therapies in dermatology is paramount for enhancing treatment efficacy and promoting patient well-being. Prevalence of Poor Adherence Poor adherence is a significant issue in dermatology, leading to suboptimal treatment outcomes, disease exacerbation, and prolonged recovery periods.

Dermatology 59

Dermatology Treatments Education Medical 59

US Dermatologt Partners

AUGUST 23, 2023

Atopic Dermatitis, more commonly known as eczema, is a common skin condition impacting one in 10 Americans. Dermatology Partners affiliate office Medical Dermatology Specialists in Phoenix, Arizona , “Like other chronic skin conditions, eczema is best managed with the help of a dermatologist.

Eczema 36

Eczema Dermatitis Management Skin Health 36

Dermatology Times

JULY 2, 2024

A medical expert in dermatology examines comprehensive treatment approaches for atopic dermatitis in a 12-year-old African American female patient, focusing on the assessment of topical and non-steroidal therapeutic options.

Dermatitis 36

Dermatitis Treatments Medical Dermatology 36

The Dermatology Digest

MAY 23, 2024

TDD Editorial Advisory Board Member Raj Chovatiya, MD, PhD, the Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, updates viewers on the true role of Malassezia yeast in the pathophysiology of seborrheic dermatitis and explains how this new understanding is changing the way the condition is treated.

Dermatitis 74

Dermatitis Dermatology Medical 74

The Dermatology Digest

OCTOBER 31, 2024

[link] Patrick Burnett, MD, PhD, Chief Medical Officer of Arcutis Biotherapeutics, reviews new data on the use of topical roflumilast (Zoryve) in scalp and body psoriasis, seborrheic dermatitis, and atopic dermatitis in patients with diverse skin types presented at the 2024 Fall Clinical Dermatology Conference in Las Vegas, NV.

Skin Types 36

Skin Types Dermatitis Office Dermatology 36

The Dermatology Digest

SEPTEMBER 14, 2023

Daniel Butler discusses strategies for diagnosing atypical dermatitis and overcoming medication access issues, including the use of alternative metrics to measure disease severity, practicing physician patience, and learning to navigate the payer system. We are so reliant on our physical exam skills [and] appropriately so. “And

Dermatitis 48

Dermatitis Treatments Medical Office 48

The Dermatology Digest

APRIL 9, 2024

Patient images are missing in studies of atopic dermatitis (AD), new research shows. ” The study is published in the Journal of Dermatological Treatment. “Images are also important for understanding that atopic dermatitis looks very different in different types of skin. This means that as little as 0.3

Eczema 74

Eczema Dermatitis Education Hospital 74

The Dermatology Digest

APRIL 7, 2024

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Ch’en, a medical student at the Albert Einstein College of Medicine in the Bronx, New York, and Peter A. The study appears in Dermatitis.

Treatments 77

Treatments Dermatitis Therapy Medical 77

The Dermatology Digest

JANUARY 4, 2024

To find out more, researchers culled the literature to better define the dermatological burden of e-cigarettes and vaping. Smoking is known to increase the risk of developing atopic dermatitis (AD), even in adolescents. Vaping and Allergic Contact Dermatitis: What’s the link?

Dermatitis 69

Dermatitis Dermatology Medical Education 69

The Dermatology Digest

FEBRUARY 6, 2024

“ASA is proud to announce that the 2024 grant opportunities to support medical and educational initiatives total nearly $750,000, which is the largest offering to date,” says ASA Chairman Howard P. The American Skin Association (ASA) announced its 2024 grant opportunities for dermatologists treating skin cancer and other diseases.

Dermatology 36

Dermatology Dermatitis Medical Education 36

The Dermatology Digest

JANUARY 29, 2024

From new topical therapies and novel biologics including nemolizumab and lebrikizumab to OX40 and OX40 ligand monoclonal antibodies, the atopic dermatitis pipeline is full, says Andrew Blauvelt, MD, MBA, an Investigator at Oregon Medical Research Center in Portland. appeared first on The Dermatology Digest.

Dermatitis 28

Dermatitis Therapy Medical Dermatology 28

The Dermatology Digest

MARCH 9, 2024

Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, explains how he is using biosimilars in his practice during a talk at the American Academy of Dermatology’s annual meeting in San Diego. Watch Now Biosimilars in Dermatology: Where Do They Fit in?

Dermatology 36

Dermatology Dermatitis Eczema Clinic 36

Dermatology Times

JUNE 10, 2024

Kristine Kucera, PA-C, MPAS, DHS, discusses prescribing a PDE-4 inhibitor for Mickey Bryson's psoriasis and atopic dermatitis, emphasizing the absence of FDA-approved medications like JAK inhibitors, while Bryson underscores the challenges of daily injections, likening it to insulin use.

Dermatitis 36

Dermatitis Management Injections Medical 36

The Dermatology Digest

MARCH 10, 2024

Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago, shares pearls on keeping pediatric patients comfortable during common dermatologic procedures. Watch Now SOCS Turns 20!

Dermatology 36

Dermatology Dermatitis Eczema Clinic 36

The Dermatology Digest

MARCH 21, 2024

March is National Sleep Awareness Month, and nighttime itching is known to keep families affected by atopic dermatitis (AD) up at night. Food and Drug Administration for VTAMA (tapinarof) cream, 1% for the topical treatment of atopic dermatitis (AD) in adults and children 2 years of age and older.

Dermatitis 68

Dermatitis Dermatology Medical Treatments 68

First Derm

APRIL 19, 2023

Online Dermatologist Cercarial Dermatitis (Swimmer’s itch) Medically reviewed by The Dermatologists and written by Dr. Alexander Börve Swimmer’s itch pictures initial stage U07.1 That is why it is given the name “cercarial” dermatitis. Receive expert dermatological advice from the comfort of your own home.

Dermatitis 40

Dermatitis Medical Document Management 40

Texas Dermatology

JUNE 8, 2023

For too long, medical research has focused primarily on the health needs of white individuals, neglecting the unique needs of people of color. Read more in our blog about the value of diversity in dermatology and the relevance of skin tone. As well as, have access to study medications, and receive compensation for time and travel.

Dermatology 36

Dermatology Skin Anatomy Dermatitis Eczema 36

The Dermatology Digest

JANUARY 14, 2024

People with seborrheic dermatitis who don’t use topical steroids are 3.5 The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. The research was presented at the 2024 Winter Clinical Dermatology Conference – Hawaii in Honolulu. Zoryve foam; 48.3% of the total study population).

Dermatitis 72

Dermatitis Dermatology Office Safety 72

The Dermatology Digest

JANUARY 22, 2024

s ZORYVE topical foam, 0.3%, is now officially available for the treatment of seborrheic dermatitis. Food and Drug Administration (FDA) approved ZORYVE foam for the treatment of seborrheic dermatitis in individuals 9 years of age and older on December 15, 2023. appeared first on The Dermatology Digest.

Dermatitis 78

Dermatitis Treatments Innovations Clinic 78

Dermatology Times

AUGUST 11, 2023

Diego Ruiz Dasilva, MD, FAAD, shares treatment approaches to atopic dermatitis, focusing on medications such as dupilumab and upadacitinib.

Dermatitis 36

Dermatitis Management Medical Treatments 36

The Dermatology Digest

JANUARY 29, 2024

Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. in seborrheic dermatitis.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

US Dermatologt Partners

NOVEMBER 25, 2023

Atopic dermatitis (AD) is a multifaceted condition that can significantly impact a patient’s quality of life. In a candid conversation between Jennifer Holman, MD, FAAD, who practices at US Dermatology Partners in Tyler, Texas, and Audrey Dean, a patient who has navigated this complex condition. Dermatology Partners.

Dermatitis 36

Dermatitis Therapy Networking Treatments 36

The Dermatology Digest

SEPTEMBER 4, 2023

Todd Schlesinger discusses cannabinoids and exosomes, including receptors and regulatory outputs, key discoveries, and anecdotal findings exosomes in dermatologic treatment. Todd Schlesinger, MD, FAAD, Medical Director, Dermatology & Laser Center of Charleston, Charleston, South Carolina. “We

Dermatology 36

Dermatology Dermatitis Sebum Rosacea 36

The Dermatology Digest

FEBRUARY 14, 2024

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

Dermatology Times

NOVEMBER 20, 2023

Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.

Office 74

Office Dermatitis Medical Dermatology 74

The Dermatology Digest

FEBRUARY 9, 2024

Early skin microbiome and metabolome signatures can predict atopic dermatitis in infants aged 6 to 18 months old, according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting. The rates of atopic dermatitis were 30.8% in 6-month-old children and 20.8% at 18 months of age.

Dermatitis 74

Dermatitis Moisturization Training Dermatology 74

The Dermatology Digest

AUGUST 23, 2024

Janus kinase (JAK) inhibitors have had game-changing effects for patients with psoriasis, atopic dermatitis, vitiligo, and alopecia areata, but the use of these potent medications has been associated with JAK inhibitor-associated acne (JAKne). Miranti, MPAS, PA-C, a Physician Assistant with Riverchase Dermatology in Naples, FL.

Dermatology 74

Dermatology Dermatitis Medical Clinic 74

The Dermatology Digest

SEPTEMBER 25, 2024

Upadacitinib (Rinvoq, AbbVie) performed well in moderate-to-severe atopic dermatitis (AD) patients with head and neck involvement, according to a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The findings were presented at at the European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam.

Dermatitis 36

Dermatitis Dermatology Eczema Safety 36

The Dermatology Digest

JUNE 5, 2024

In the cross-sectional study, researchers analyzed data from more than 215,000 people aged 30 to 70 from the UK Biobank, which includef urine samples and electronic medical records. The post High-salt Diets Linked to Eczema appeared first on The Dermatology Digest.

Eczema 74

Eczema Diet Dermatitis Dermatology 74

The Dermatology Digest

MARCH 11, 2024

Emma Guttman-Yassky, MD, PhD, the Waldman Professor of Dermatology and Immunology and Health System Chair of Dermatology at the Icahn School of Medicine at Mount Sinai in New York City, shares results from a late-breaker that she presented at the annual meeting of the American Academy of Dermatology in San Diego, CA.

Dermatitis 69

Dermatitis Eczema Dermatology Pharmaceutical 69

First Derm

MARCH 22, 2024

Eczema herpeticum Medically reviewed by The Dermatologists and written by Dr. Alexander Börve In A Nutshell What It Is : Skin infection marked by fever and clusters of itchy blisters, often complicating atopic dermatitis. Those with atopic dermatitis have lower resistance to the herpes infection. What is Eczema Herpeticum?

Eczema 52

Eczema Dermatitis Clinic Medical 52

The Dermatology Digest

JANUARY 31, 2024

Patients with vitiligo incur significantly higher healthcare costs than people without this skin condition, finds a new study in the Journal of Investigative Dermatology. ” –Khaled Ezzedine, MD, PhD, of the Department of Dermatology at AP-HP at Henri Mondor University Hospital in Créteil, France, in a news release. .

Hospital 69

Hospital Dermatitis Dermatology Medical 69

First Derm

OCTOBER 14, 2023

Online Dermatologist Cannabinoids for the Treatment of Dermatologic Conditions Psychoactive Components | Cannabinoid Use in Dermatology | Classes of Cannabinoids | Cannabinoids for skin conditions The field of dermatology has witnessed a remarkable evolution in recent years, with the integration of cannabinoids into treatment regimens.

Dermatology 40

Dermatology Treatments Dermatitis Innovations 40

First Derm

JUNE 23, 2024

1] Three main categories of eczema are atopic eczema, contact dermatitis and stasis dermatitis. Despite the potential side effects, appropriate use of topical steroids under medical advice is beneficial for controlling eczema. [4] The American Contact Dermatitis Society recognizes it as an allergen.

Eczema 59

Eczema Ingredients Dermatitis Irritation 59

The Dermatology Digest

OCTOBER 26, 2024

Atopic dermatitis (AD) patients who switched to upadacitinib (Rinvoq, AbbVie) from dupilumab (Dupixent, Regeneron, and Sanofi) hit higher treatment targets, according to results from Period 2 of the LEVEL UP study. The most frequently reported TEAEs included nasopharyngitis, acne, upper respiratory tract infection, and atopic dermatitis.

Dermatitis 36

Dermatitis Treatments Pharmaceutical Eczema 36